PubMed:26931464 / 1985-2083
Annnotations
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | proteinmutation |
|---|---|---|---|---|---|
| 26931464_7 | 78-84 | ProteinMutation | denotes | G2019S | rs34637584 |
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T288 | 18-28 | 6472 | denotes | lovastatin |
| T286 | 18-28 | D008148 | denotes | lovastatin |
| T287 | 18-28 | D008148 | denotes | lovastatin |
| T289 | 18-28 | CHEBI:40303 | denotes | lovastatin |
| T290 | 44-51 | D004194 | denotes | disease |
| T291 | 44-51 | D004194 | denotes | disease |
| T292 | 72-77 | PR:Q5S006 | denotes | LRRK2 |
| T293 | 72-77 | PR:000003033 | denotes | LRRK2 |
| T294 | 72-77 | PR:Q5S007 | denotes | LRRK2 |
| T295 | 85-97 | D020734 | denotes | parkinsonism |
| T296 | 85-97 | D020734 | denotes | parkinsonism |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 0-98 | DRI_Approach | denotes | We suggested that lovastatin is a potential disease-modifying agent for LRRK2-G2019S parkinsonism. |